Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by Hobberson Apr 09, 2013 10:15am
225 Views
Post# 21230603

RE: RE: RVXCF

RE: RE: RVXCF

 

Here's another confirmation. I wanted an e-mail response from RVX for the record and for future reference, if it ever was needed.

 

I e-mailed Sarah last night asking for clarification of the RVX/RVXCF situation as it relates to US investors and the spin-out. Her response is below.

 

As an aside, I, too, hold shares in a Schwab account here in the US. Like expattrader, I talked to the guys on their global desk who deal in this stuff all day long. They said that on-line orders (which I use) are routed through the global desk directly to the Toronto Exchange and shares are bought there by Schwab and entered into my account with the CF attached denoting a foreign security. Exchange rates continually affect price. They said there should be no problem with the spinout since these are Toronto Exchange issued shares. CUSIP numbers also match as they should.

 

Here is Sarah's response:

 

Please check the CUSIP number on your share certificate. If it is 761-28M 108 then you hold valid TSX shares eligible for the spin-out.

 

Thank you,

Sarah

-------------------

 

All mine match that number.

Bullboard Posts